Buy XTL Biopharmaceuticals Stock | XTLB Stock Price & Latest News | Public

XTL Biopharmaceuticals

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About XTLB

    XTL Biopharmaceuticals Ltd. focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company was founded on March 9, 1993 and is headquartered in Raanana, Israel. T...Read more

    Community

    People who own or watch this stock

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Rating

    What Wall St. analysts suggest for this stock

    1

    Price Targets

    What analysts think this stock will be worth

    $1.47
    current
    $6.00
    average

    Stats

    Market Cap$7,61M
    Volume1,2k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$2.16
    1 Year Low$0.63
    Open$1.47
    High$1.47
    Low$1.47

    Buy any stock with any amount of money.

    Download the App
    Download the app